Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/97424
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma
Author: Hutson, T.
Escudier, B.
Esteban, E.
Bjarnason, G.
Lim, H.
Pittman, K.
Senico, P.
Niethammer, A.
Lu, D.
Hariharan, S.
Motzer, R.
Citation: Journal of Clinical Oncology, 2014; 32(8):760-767
Publisher: American Society of Clinical Oncology
Issue Date: 2014
ISSN: 0732-183X
1527-7755
Statement of
Responsibility: 
Thomas E. Hutson, Bernard Escudier, Emilio Esteban, Georg A. Bjarnason, Ho Yeong Lim, Kenneth B. Pittman, Peggy Senico, Andreas Niethammer, Dongrui Ray Lu, Subramanian Hariharan, and Robert J. Motzer
Abstract: Abstract not available
Keywords: Humans
Description: Published online before print December 2, 2013
Rights: © 2013 by American Society of Clinical Oncology
RMID: 0030026761
DOI: 10.1200/JCO.2013.50.3961
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.